-
1
-
-
1542267219
-
Graft-versus-leukemia reactions in allogeneic chimeras
-
DOI 10.1182/blood-2003-02-0342
-
Kolb, HJ, Schmid, C, Barrett, AJ and Schendel, DJ (2004). Graft-versus-leukemia reactions in allogeneic chimeras. Blood 103: 767-776. (Pubitemid 38129531)
-
(2004)
Blood
, vol.103
, Issue.3
, pp. 767-776
-
-
Kolb, H.-J.1
Schmid, C.2
Barrett, A.J.3
Schendel, D.J.4
-
2
-
-
12744274892
-
Adoptive immunotherapy for EBVassociated malignancies
-
Gottschalk, S, Heslop, HE and Rooney, CM (2005). Adoptive immunotherapy for EBVassociated malignancies. Leuk Lymphoma 46: 1-10.
-
(2005)
Leuk Lymphoma
, vol.46
, pp. 1-10
-
-
Gottschalk, S.1
Heslop, H.E.2
Rooney, C.M.3
-
3
-
-
65249173447
-
Adoptive cell therapy for the treatment of patients with metastatic melanoma
-
Rosenberg, SA and Dudley, ME (2009). Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol 21: 233-240.
-
(2009)
Curr Opin Immunol
, vol.21
, pp. 233-240
-
-
Rosenberg, S.A.1
Dudley, M.E.2
-
4
-
-
33749624177
-
Cancer regression in patients after transfer of genetically engineered lymphocytes
-
DOI 10.1126/science.1129003
-
Morgan, RA, Dudley, ME, Wunderlich, JR, Hughes, MS, Yang, JC, Sherry, RM et al. (2006). Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314: 126-129. (Pubitemid 44547756)
-
(2006)
Science
, vol.314
, Issue.5796
, pp. 126-129
-
-
Morgan, R.A.1
Dudley, M.E.2
Wunderlich, J.R.3
Hughes, M.S.4
Yang, J.C.5
Sherry, R.M.6
Royal, R.E.7
Topalian, S.L.8
Kammula, U.S.9
Restifo, N.P.10
Zheng, Z.11
Nahvi, A.12
De Vries, C.R.13
Rogers-Freezer, L.J.14
Mavroukakis, S.A.15
Rosenberg, S.A.16
-
5
-
-
70149114880
-
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
-
Johnson, LA, Morgan, RA, Dudley, ME, Cassard, L, Yang, JC, Hughes, MS et al. (2009). Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 114: 535-546.
-
(2009)
Blood
, vol.114
, pp. 535-546
-
-
Johnson, L.A.1
Morgan, R.A.2
Dudley, M.E.3
Cassard, L.4
Yang, J.C.5
Hughes, M.S.6
-
6
-
-
38449095735
-
The T-body approach: Redirecting T cells with antibody specificity
-
Eshhar, Z (2008). The T-body approach: redirecting T cells with antibody specificity. Handb Exp Pharmacol 329-342.
-
(2008)
Handb Exp Pharmacol
, pp. 329-342
-
-
Eshhar, Z.1
-
7
-
-
17044378252
-
Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation
-
Friedmann-Morvinski, D, Bendavid, A, Waks, T, Schindler, D and Eshhar, Z (2005). Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation. Blood 105: 3087-3093.
-
(2005)
Blood
, vol.105
, pp. 3087-3093
-
-
Friedmann-Morvinski, D.1
Bendavid, A.2
Waks, T.3
Schindler, D.4
Eshhar, Z.5
-
8
-
-
0035576250
-
Tumor-specific T cell activation by recombinant immunoreceptors: CD3ζ signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3ζ signaling receptor molecule
-
Hombach, A, Wieczarkowiecz, A, Marquardt, T, Heuser, C, Usai, L, Pohl, C et al. (2001). Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule. J Immunol 167: 6123-6131. (Pubitemid 33081538)
-
(2001)
Journal of Immunology
, vol.167
, Issue.11
, pp. 6123-6131
-
-
Hombach, A.1
Wieczarkowiecz, A.2
Marquardt, T.3
Heuser, C.4
Usai, L.5
Pohl, C.6
Seliger, B.7
Abken, H.8
-
9
-
-
0032531091
-
Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product
-
Finney, HM, Lawson, AD, Bebbington, CR and Weir, AN (1998). Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product. J Immunol 161: 2791-2797. (Pubitemid 28425698)
-
(1998)
Journal of Immunology
, vol.161
, Issue.6
, pp. 2791-2797
-
-
Finney, H.M.1
Lawson, A.D.G.2
Bebbington, C.R.3
Weir, A.N.C.4
-
10
-
-
50549096284
-
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
-
Till, BG, Jensen, MC, Wang, J, Chen, EY, Wood, BL, Greisman, HA et al. (2008). Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells. Blood 112: 2261-2271.
-
(2008)
Blood
, vol.112
, pp. 2261-2271
-
-
Till, B.G.1
Jensen, M.C.2
Wang, J.3
Chen, E.Y.4
Wood, B.L.5
Greisman, H.A.6
-
11
-
-
34247261531
-
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
-
DOI 10.1200/JCO.2006.05.9584
-
Bates, GJ, Fox, SB, Han, C, Leek, RD, Garcia, JF, Harris, AL et al. (2006). Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24: 5373-5380. (Pubitemid 46623168)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.34
, pp. 5373-5380
-
-
Bates, G.J.1
Fox, S.B.2
Han, C.3
Leek, R.D.4
Garcia, J.F.5
Harris, A.L.6
Banham, A.H.7
-
12
-
-
28544433483
-
The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer
-
DOI 10.1158/1078-0432.CCR-05-1244
-
Wolf, D, Wolf, AM, Rumpold, H, Fiegl, H, Zeimet, AG, Muller-Holzner, E et al. (2005). The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 11: 8326-8331. (Pubitemid 41746944)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.23
, pp. 8326-8331
-
-
Wolf, D.1
Wolf, A.M.2
Rumpold, H.3
Fiegl, H.4
Zeimet, A.G.5
Muller-Holzner, E.6
Deibl, M.7
Gastl, G.8
Gunsilius, E.9
Marth, C.10
-
13
-
-
58249089749
-
Tumorinfiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer
-
Salama, P, Phillips, M, Grieu, F, Morris, M, Zeps, N, Joseph, D et al. (2009). Tumorinfiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27: 186-192.
-
(2009)
J Clin Oncol
, vol.27
, pp. 186-192
-
-
Salama, P.1
Phillips, M.2
Grieu, F.3
Morris, M.4
Zeps, N.5
Joseph, D.6
-
14
-
-
31644440643
-
Regulatory cells and human cancer
-
DOI 10.1016/j.semcancer.2005.11.003, PII S1044579X05000738, Regulating the Regulators or How ti Elicit an Immune Response
-
Baecher-Allan, C and Anderson, DE (2006). Regulatory cells and human cancer. Semin Cancer Biol 16: 98-105. (Pubitemid 43172058)
-
(2006)
Seminars in Cancer Biology
, vol.16
, Issue.2
, pp. 98-105
-
-
Baecher-Allan, C.1
Anderson, D.E.2
-
15
-
-
33847384529
-
+ regulatory T cells affect the development and progression of hepatocarcinogenesis
-
DOI 10.1158/1078-0432.CCR-06-2363
-
Kobayashi, N, Hiraoka, N, Yamagami, W, Ojima, H, Kanai, Y, Kosuge, T et al. (2007). FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 13: 902-911. (Pubitemid 46340366)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.3
, pp. 902-911
-
-
Kobayashi, N.1
Hiraoka, N.2
Yamagami, W.3
Ojima, H.4
Kanai, Y.5
Kosuge, T.6
Nakajima, A.7
Hirohashi, S.8
-
16
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
-
DOI 10.1038/nm1093
-
Curiel, TJ, Coukos, G, Zou, L, Alvarez, X, Cheng, P, Mottram, P et al. (2004). Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942-949. (Pubitemid 39273735)
-
(2004)
Nature Medicine
, vol.10
, Issue.9
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
Evdemon-Hogan, M.7
Conejo-Garcia, J.R.8
Zhang, L.9
Burow, M.10
Zhu, Y.11
Wei, S.12
Kryczek, I.13
Daniel, B.14
Gordon, A.15
Myers, L.16
Lackner, A.17
Disis, M.L.18
Knutson, K.L.19
Chen, L.20
Zou, W.21
more..
-
17
-
-
65549136983
-
Mechanisms of foxp3+ T regulatory cell-mediated suppression
-
Shevach, EM (2009). Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.
-
(2009)
Immunity
, vol.30
, pp. 636-645
-
-
Shevach, E.M.1
-
18
-
-
39449126502
-
+ regulatory T cell: A jack of all trades, master of regulation
-
DOI 10.1038/ni1572, PII NI1572
-
Tang, Q and Bluestone, JA (2008). The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9: 239-244. (Pubitemid 351267321)
-
(2008)
Nature Immunology
, vol.9
, Issue.3
, pp. 239-244
-
-
Tang, Q.1
Bluestone, J.A.2
-
19
-
-
49649124868
-
IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells
-
Brandenburg, S, Takahashi, T, de la Rosa, M, Janke, M, Karsten, G, Muzzulini, T et al. (2008). IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells. Eur J Immunol 38: 1643-1653.
-
(2008)
Eur J Immunol
, vol.38
, pp. 1643-1653
-
-
Brandenburg, S.1
Takahashi, T.2
De La Rosa, M.3
Janke, M.4
Karsten, G.5
Muzzulini, T.6
-
20
-
-
33644784733
-
+ regulatory T cells in cancer patients
-
DOI 10.1182/blood-2005-06-2399
-
Ahmadzadeh, M and Rosenberg, SA (2006). IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood 107: 2409-2414. (Pubitemid 43345561)
-
(2006)
Blood
, vol.107
, Issue.6
, pp. 2409-2414
-
-
Ahmadzadeh, M.1
Rosenberg, S.A.2
-
21
-
-
63549105681
-
Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients
-
Ko, JS, Zea, AH, Rini, BI, Ireland, JL, Elson, P, Cohen, P et al. (2009). Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin Cancer Res 15: 2148-2157.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 2148-2157
-
-
Ko, J.S.1
Zea, A.H.2
Rini, B.I.3
Ireland, J.L.4
Elson, P.5
Cohen, P.6
-
22
-
-
24744432528
-
hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine
-
DOI 10.1182/blood-2005-02-0642
-
Beyer, M, Kochanek, M, Darabi, K, Popov, A, Jensen, M, Endl, E et al. (2005). Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood 106: 2018-2025. (Pubitemid 41291715)
-
(2005)
Blood
, vol.106
, Issue.6
, pp. 2018-2025
-
-
Beyer, M.1
Kochanek, M.2
Darabi, K.3
Popov, A.4
Jensen, M.5
Endl, E.6
Knolle, P.A.7
Thomas, R.K.8
Von Bergwelt-Baildon, M.9
Debey, S.10
Hallek, M.11
Schultze, J.L.12
-
23
-
-
0028124259
-
Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern
-
Eades-Perner, AM, van der Putten, H, Hirth, A, Thompson, J, Neumaier, M, von Kleist, S et al. (1994). Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern. Cancer Res 54: 4169-4176.
-
(1994)
Cancer Res
, vol.54
, pp. 4169-4176
-
-
Eades-Perner, A.M.1
Van Der Putten, H.2
Hirth, A.3
Thompson, J.4
Neumaier, M.5
Von Kleist, S.6
-
24
-
-
0035266137
-
T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis
-
Hombach, A, Sent, D, Schneider, C, Heuser, C, Koch, D, Pohl, C et al. (2001). T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptormediated target cell lysis. Cancer Res 61: 1976-1982. (Pubitemid 32692016)
-
(2001)
Cancer Research
, vol.61
, Issue.5
, pp. 1976-1982
-
-
Hombach, A.1
Sent, D.2
Schneider, C.3
Heuser, C.4
Koch, D.5
Pohl, C.6
Seliger, B.7
Abken, H.8
-
25
-
-
69449086689
-
Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells
-
Wang, R, Kozhaya, L, Mercer, F, Khaitan, A, Fujii, H and Unutmaz, D (2009). Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 106: 13439-13444.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 13439-13444
-
-
Wang, R.1
Kozhaya, L.2
Mercer, F.3
Khaitan, A.4
Fujii, H.5
Unutmaz, D.6
-
26
-
-
77951638740
-
Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells
-
Thornton, AM, Korty, PE, Tran, DQ, Wohlfert, EA, Murray, PE, Belkaid, Y et al. (2010). Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184: 3433-3441.
-
(2010)
J Immunol
, vol.184
, pp. 3433-3441
-
-
Thornton, A.M.1
Korty, P.E.2
Tran, D.Q.3
Wohlfert, E.A.4
Murray, P.E.5
Belkaid, Y.6
-
27
-
-
2442637772
-
+ T cell suppressor function
-
Thornton, AM, Donovan, EE, Piccirillo, CA and Shevach, EM (2004). Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 172: 6519-6523. (Pubitemid 38669083)
-
(2004)
Journal of Immunology
, vol.172
, Issue.11
, pp. 6519-6523
-
-
Thornton, A.M.1
Donovan, E.E.2
Piccirillo, C.A.3
Shevach, E.M.4
-
28
-
-
58149182887
-
CD45 downregulates Lck-mediated CD44 signaling and modulates actin rearrangement in T cells
-
Wong, NK, Lai, JC, Birkenhead, D, Shaw, AS and Johnson, P (2008). CD45 downregulates Lck-mediated CD44 signaling and modulates actin rearrangement in T cells. J Immunol 181: 7033-7043.
-
(2008)
J Immunol
, vol.181
, pp. 7033-7043
-
-
Wong, N.K.1
Lai, J.C.2
Birkenhead, D.3
Shaw, A.S.4
Johnson, P.5
-
29
-
-
33947496068
-
'Vive la Résistance!' - the PI3K-Akt pathway can determine target sensitivity to regulatory T cell suppression
-
DOI 10.1016/j.it.2007.02.003, PII S1471490607000294
-
Wohlfert, EA and Clark, RB (2007). 'Vive la Résistance!'-the PI3K-Akt pathway can determine target sensitivity to regulatory T cell suppression. Trends Immunol 28: 154-160. (Pubitemid 46467517)
-
(2007)
Trends in Immunology
, vol.28
, Issue.4
, pp. 154-160
-
-
Wohlfert, E.A.1
Clark, R.B.2
-
30
-
-
17244378876
-
MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: A novel defect of T cell regulation in systemic lupus erythematosus
-
DOI 10.1002/art.20976
-
Monk, CR, Spachidou, M, Rovis, F, Leung, E, Botto, M, Lechler, RI et al. (2005). MRL/ Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum 52: 1180-1184. (Pubitemid 40530125)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.4
, pp. 1180-1184
-
-
Monk, C.R.1
Spachidou, M.2
Rovis, F.3
Leung, E.4
Botto, M.5
Lechler, R.I.6
Garden, O.A.7
-
31
-
-
20944444896
-
Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells
-
DOI 10.2337/diabetes.54.5.1415
-
You, S, Belghith, M, Cobbold, S, Alyanakian, MA, Gouarin, C, Barriot, S et al. (2005). Autoimmune diabetes onset results from qualitative rather than quantitative agedependent changes in pathogenic T-cells. Diabetes 54: 1415-1422. (Pubitemid 40586672)
-
(2005)
Diabetes
, vol.54
, Issue.5
, pp. 1415-1422
-
-
You, S.1
Belghith, M.2
Cobbold, S.3
Alyanakian, M.-A.4
Gouarin, C.5
Barriot, S.6
Garcia, C.7
Waldmann, H.8
Bach, J.-F.9
Chatenoud, L.10
-
32
-
-
3142782879
-
Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b-/- mice
-
Wohlfert, EA, Callahan, MK and Clark, RB (2004). Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b-/- mice. J Immunol 173: 1059-1065.
-
(2004)
J Immunol
, vol.173
, pp. 1059-1065
-
-
Wohlfert, E.A.1
Callahan, M.K.2
Clark, R.B.3
-
33
-
-
33748460821
-
TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis
-
DOI 10.1038/nm1449, PII NM1449
-
King, CG, Kobayashi, T, Cejas, PJ, Kim, T, Yoon, K, Kim, GK et al. (2006). TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis. Nat Med 12: 1088-1092. (Pubitemid 44353391)
-
(2006)
Nature Medicine
, vol.12
, Issue.9
, pp. 1088-1092
-
-
King, C.G.1
Kobayashi, T.2
Cejas, P.J.3
Kim, T.4
Yoon, K.5
Kim, G.K.6
Chiffoleau, E.7
Hickman, S.P.8
Walsh, P.T.9
Turka, L.A.10
Choi, Y.11
-
34
-
-
15444363794
-
+ regulatory T cells
-
DOI 10.1084/jem.20040685
-
Fahlén, L, Read, S, Gorelik, L, Hurst, SD, Coffman, RL, Flavell, RA et al. (2005). T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med 201: 737-746. (Pubitemid 40395119)
-
(2005)
Journal of Experimental Medicine
, vol.201
, Issue.5
, pp. 737-746
-
-
Fahlen, L.1
Read, S.2
Gorelik, L.3
Hurst, S.D.4
Coffman, R.L.5
Flavell, R.A.6
Powrie, F.7
-
35
-
-
19944434216
-
+ regulatory T cells
-
DOI 10.1084/jem.20041538
-
Bopp, T, Palmetshofer, A, Serfling, E, Heib, V, Schmitt, S, Richter, C et al. (2005). NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells. J Exp Med 201: 181-187. (Pubitemid 40189426)
-
(2005)
Journal of Experimental Medicine
, vol.201
, Issue.2
, pp. 181-187
-
-
Bopp, T.1
Palmetshofer, A.2
Serfling, E.3
Heib, V.4
Schmitt, S.5
Richter, C.6
Klein, M.7
Schild, H.8
Schmitt, E.9
Stassen, M.10
-
36
-
-
0035555195
-
Proteolysis-independent regulation of PI3K by Cbl-bmediated ubiquitination in T cells
-
Fang, D and Liu, YC (2001). Proteolysis-independent regulation of PI3K by Cbl-bmediated ubiquitination in T cells. Nat Immunol 2: 870-875.
-
(2001)
Nat Immunol
, vol.2
, pp. 870-875
-
-
Fang, D.1
Liu, Y.C.2
-
37
-
-
33750061330
-
Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cells
-
DOI 10.1038/sj.leu.2404366, PII 2404366
-
Loskog, A, Giandomenico, V, Rossig, C, Pule, M, Dotti, G and Brenner, MK (2006). Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cells. Leukemia 20: 1819-1828. (Pubitemid 44574993)
-
(2006)
Leukemia
, vol.20
, Issue.10
, pp. 1819-1828
-
-
Loskog, A.1
Giandomenico, V.2
Rossig, C.3
Pule, M.4
Dotti, G.5
Brenner, M.K.6
-
38
-
-
33947203783
-
+ T cells in an antitumor cell attack
-
DOI 10.1158/0008-5472.CAN-06-2098
-
Koehler, H, Kofler, D, Hombach, A and Abken, H (2007). CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack. Cancer Res 67: 2265-2273. (Pubitemid 46424246)
-
(2007)
Cancer Research
, vol.67
, Issue.5
, pp. 2265-2273
-
-
Koehler, H.1
Kofler, D.2
Hombach, A.3
Abken, H.4
-
39
-
-
41149097574
-
Adoptive cell transfer: A clinical path to effective cancer immunotherapy
-
DOI 10.1038/nrc2355, PII NRC2355
-
Rosenberg, SA, Restifo, NP, Yang, JC, Morgan, RA and Dudley, ME (2008). Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8: 299-308. (Pubitemid 351430867)
-
(2008)
Nature Reviews Cancer
, vol.8
, Issue.4
, pp. 299-308
-
-
Rosenberg, S.A.1
Restifo, N.P.2
Yang, J.C.3
Morgan, R.A.4
Dudley, M.E.5
-
40
-
-
60849098427
-
IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive selfrenewing central memory human T lymphocytes
-
Kaneko, S, Mastaglio, S, Bondanza, A, Ponzoni, M, Sanvito, F, Aldrighetti, L et al. (2009). IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive selfrenewing central memory human T lymphocytes. Blood 113: 1006-1015.
-
(2009)
Blood
, vol.113
, pp. 1006-1015
-
-
Kaneko, S.1
Mastaglio, S.2
Bondanza, A.3
Ponzoni, M.4
Sanvito, F.5
Aldrighetti, L.6
-
41
-
-
34447569374
-
Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes
-
DOI 10.1002/jgm.1047
-
Pouw, NM, Westerlaken, EJ, Willemsen, RA and Debets, R (2007). Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes. J Gene Med 9: 561-570. (Pubitemid 47073988)
-
(2007)
Journal of Gene Medicine
, vol.9
, Issue.7
, pp. 561-570
-
-
Pouw, N.M.C.1
Westerlaken, E.J.2
Willemsen, R.A.3
Debets, R.4
-
42
-
-
34147092225
-
+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses
-
DOI 10.1016/j.jim.2007.01.025, PII S0022175907000518
-
Venken, K, Thewissen, M, Hellings, N, Somers, V, Hensen, K, Rummens, JL et al. (2007). A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J Immunol Methods 322: 1-11. (Pubitemid 46560587)
-
(2007)
Journal of Immunological Methods
, vol.322
, Issue.1-2
, pp. 1-11
-
-
Venken, K.1
Thewissen, M.2
Hellings, N.3
Somers, V.4
Hensen, K.5
Rummens, J.-L.6
Stinissen, P.7
|